Breaking Stories

IPO Report: 23andMe shares surge 17% in their trading debut after merger with Richard Branson-backed SPAC


Shares of consumer genetics company 23andMe rose about 17% in their trading debut Thursday, after the provider of home DNA test kits went public via a merger with Richard Branson’s special-purpose acquisition corporation, or SPAC, VG Acquisition Corp.

IPO Report: Krispy Kreme IPO: 5 things to know about the doughnut maker before it goes public

Previous article

The Moneyist: ‘It makes me angry’: My husband’s ex-wife has a $1 million insurance policy on his life. Can we cancel it?

Next article

You may also like


Leave a reply

Your email address will not be published. Required fields are marked *